DPN in nursing stands for diabetic peripheral neuropathy, a common complication of diabetes that damages nerves in the hands and feet. It affects roughly 50% of adults with diabetes over their lifetime, making it one of the most frequent conditions nurses encounter in diabetic patient care. Nurses play a central role in screening for DPN, educating patients about foot protection, and monitoring treatments.
What Diabetic Peripheral Neuropathy Is
DPN is defined as the presence of symptoms or signs of peripheral nerve dysfunction in people with diabetes, after other causes have been ruled out. It primarily affects the small nerve fibers that carry sensation to the feet and hands, which is why numbness, tingling, and pain in those areas are hallmark complaints. The damage typically starts in the toes and works its way upward in a “stocking-glove” pattern, meaning it affects both sides of the body symmetrically.
The danger of DPN goes beyond discomfort. When patients lose sensation in their feet, small cuts, blisters, or pressure sores can go unnoticed and develop into serious infections or ulcers. This is a leading cause of lower limb amputation in people with diabetes, which is why nursing assessment and patient education around DPN carry real clinical weight.
How High Blood Sugar Damages Nerves
Chronically elevated blood sugar triggers a chain of events inside nerve cells. Excess glucose gets shunted through an alternative chemical pathway that disrupts the nerve’s outer membrane, interfering with how the nerve handles electrolytes and proteins. This causes swelling around the nerve, and the progressive buildup of fluid eventually cuts off blood flow, leading to ischemic damage.
At the same time, high blood sugar ramps up production of harmful molecules called reactive oxygen species. These molecules damage the fatty coatings around nerve fibers and interfere with the proteins nerves need to function. Research has found that people with diabetes who have lower levels of the body’s natural antioxidant defenses are significantly more likely to develop DPN. The combination of swelling, reduced blood flow, and oxidative damage explains why nerve injury in diabetes tends to be gradual, progressive, and difficult to reverse once established.
When and How Nurses Screen for DPN
The American Diabetes Association recommends that all people with type 2 diabetes be screened for DPN starting at diagnosis, since many already have nerve damage by the time they’re identified. For type 1 diabetes, screening should begin five years after diagnosis. After the initial assessment, screening should happen at least once a year.
A standard screening includes four components: a careful patient history asking about numbness, tingling, or burning; a temperature or pinprick test to check small-fiber nerve function; vibration testing with a 128-Hz tuning fork on the big toe to assess large-fiber function; and a 10-gram monofilament test to identify feet at risk for ulceration. The monofilament test involves pressing a thin, flexible filament against specific points on the sole of the foot. If the patient can’t feel it, protective sensation has been lost.
The Michigan Neuropathy Screening Instrument
One of the most widely used tools is the Michigan Neuropathy Screening Instrument (MNSI), which has two parts. The first is a 15-question self-reported survey where patients answer yes or no to questions about foot sensation, pain, numbness, and temperature sensitivity. It’s scored out of 13 points (two questions are excluded from scoring because they measure circulation and general asesthesia rather than neuropathy). A score of 7 or higher suggests neuropathy.
The second part is a brief physical exam performed by the nurse or clinician. It includes inspecting both feet for deformities, dry skin, nail abnormalities, calluses, or infection; checking vibration sensation on the big toe; grading ankle reflexes; and performing monofilament testing. This exam is scored on a 10-point scale across both feet, and a score greater than 2 indicates neuropathy and warrants referral for further evaluation.
Patient Education: Foot Care Essentials
Teaching patients how to protect their feet is one of the most impactful nursing interventions for DPN. Because patients may not feel injuries as they happen, daily self-inspection becomes critical. Nurses should instruct patients to check their feet every day for sores, cuts, blisters, redness, or corns, using a mirror if needed to see the bottoms of their feet.
Key teaching points include:
- Washing: Use warm (not hot) soapy water daily. Patients with neuropathy often can’t gauge water temperature accurately, so testing with an elbow or thermometer prevents burns.
- Drying and moisturizing: Dry feet thoroughly after washing and apply a gentle moisturizer, but avoid putting lotion between the toes, where trapped moisture can cause fungal infections.
- Footwear: Never go barefoot, even at home. Wear well-fitting, sturdy shoes and check inside them before putting them on for small objects like pebbles that could cause injury. Moisture-wicking socks help keep feet dry.
- Activity precautions: Avoid walking on open sores. If standard shoes cause discomfort, therapeutic shoes or custom inserts may be appropriate.
Medications and Nursing Considerations
DPN has no cure, but several medications help manage the nerve pain. Two drugs are FDA-approved specifically for DPN pain, and nurses should be familiar with the monitoring each one requires.
Duloxetine is widely recommended as a first-line treatment at a standard dose of 60 mg per day. It works by increasing the activity of chemical messengers in the brain and spinal cord that help dampen pain signals. Nurses should monitor blood pressure before treatment starts and periodically throughout, along with mental status changes and liver function.
Pregabalin is also FDA-approved for DPN and is the preferred treatment in some guidelines. It calms overactive nerve signals that cause pain. Nursing monitoring for pregabalin focuses on sedation level, unexplained muscle pain, vision changes, weight gain, swelling, and skin integrity, which is especially important in patients with diabetes who already heal slowly.
Amitriptyline, an older antidepressant, is used as an alternative at many centers, typically dosed at bedtime because it causes drowsiness. It requires blood pressure and heart rate monitoring, along with an ECG before and during early treatment. It’s generally avoided in patients over 60 due to a higher risk of side effects like falls and heart rhythm changes.
The Nursing Role in Long-Term DPN Management
Beyond screening and medication monitoring, nurses coordinate several ongoing aspects of DPN care. Blood sugar control remains the single most important factor in slowing nerve damage progression, so reinforcing glycemic management during every patient encounter matters. Nurses also assess for autonomic neuropathy, which can develop alongside DPN and affects heart rate, digestion, bladder function, and blood pressure regulation. The ADA recommends screening for autonomic symptoms on the same timeline as DPN screening.
Documenting the progression of symptoms over time helps the care team adjust treatment plans. Noting changes in monofilament test results, new areas of numbness, or the development of foot deformities gives clinicians a clear picture of whether the condition is stable or worsening. For patients who have lost protective sensation, coordinating referrals to podiatry and ensuring access to proper footwear can be the difference between keeping a limb and losing one.